Medprin Regenerative Medical Technologies Co. Ltd.
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a S… Read more
Medprin Regenerative Medical Technologies Co. Ltd. (301033) - Total Liabilities
Latest total liabilities as of June 2025: CN¥88.79 Million CNY
Based on the latest financial reports, Medprin Regenerative Medical Technologies Co. Ltd. (301033) has total liabilities worth CN¥88.79 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medprin Regenerative Medical Technologies Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Medprin Regenerative Medical Technologies Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medprin Regenerative Medical Technologies Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Medprin Regenerative Medical Technologies Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Semapa
LS:SEM
|
Portugal | €3.38 Billion |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
USA | $2.35 Billion |
|
CapitaLand Malaysia Mall Trust
KLSE:5180
|
Malaysia | RM2.44 Billion |
|
Delcath Systems Inc
NASDAQ:DCTH
|
USA | $12.41 Million |
|
HEG Limited
NSE:HEG
|
India | ₹12.75 Billion |
|
Firm Capital Mortgage Investment Corporation
PINK:FCMGF
|
USA | $172.56 Million |
|
RITES Limited
NSE:RITES
|
India | ₹33.18 Billion |
|
Guangdong Delian Group Co Ltd
SHE:002666
|
China | CN¥1.67 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Medprin Regenerative Medical Technologies Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medprin Regenerative Medical Technologies Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥99.57 Million | -34.11% |
| 2023-12-31 | CN¥151.11 Million | +6.16% |
| 2022-12-31 | CN¥142.34 Million | -16.72% |
| 2021-12-31 | CN¥170.92 Million | +45.75% |
| 2020-12-31 | CN¥117.26 Million | +214.62% |
| 2019-12-31 | CN¥37.27 Million | -- |